GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?

Int J Cardiol. 2022 Nov 1:366:31. doi: 10.1016/j.ijcard.2022.07.015. Epub 2022 Jul 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Stroke* / diagnosis
  • Stroke* / epidemiology

Substances

  • Sodium-Glucose Transporter 2 Inhibitors